- Ritika Ganju - 30-01-2019
Amidst the on-going heated debate on expanding the scope of the pharmaceuticals and medical devices being subject to price control, the Department of Pharmaceuticals recently notified certain exemptions from the drug price control regime, which are likely to be an encouragement for new drug manufacturers especially, foreign manufacturers.
Read More